Oxidative stress activates transcription factor Nf-κB-mediated protective signaling in primary rat neuronal cultures

Journal of Molecular Neuroscience

Volumn 26, Issue 1, 2005, Pages 27-32

  Kratsovnik, Ella ^a   Bromberg, Yael ^a   Sperling, Oded ^a   Zoref Shani, Esther ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antioxidants; I B ; Pyrrolidine dithiocarbamate (PDTC); Reactive oxygen species (ROS); SN50; Transcription factor nuclear factor B (NF B)

Indexed keywords

2,6 DI TERT BUTYL 4 [(ETHYLAMINO)METHYL]PHENOL; DITHIOCARBAMIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTATE DEHYDROGENASE; MELATONIN; PYRROLIDINE DERIVATIVE; SALICYLATE SODIUM; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; ENZYME RELEASE; NERVE CELL; NERVE INJURY; NONHUMAN; OXIDATIVE STRESS; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANTIOXIDANTS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; EMBRYO; IODOACETATES; NEURONS; NF-KAPPA B; OXIDATIVE STRESS; RATS; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 22344447847     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:26:03:27     Document Type: Article

References (32)

1. Bhakar A. L, Tannis L. L., Zeindler C., Russo M. P., Jobin C., Park D. S., et al. (2002) Constitutive nuclear factor-kappaB activity is required for central neuron survival. J. Neurosci. 22, 8466-8475.
2. Blondeau N., Plamondon H., Richelme C., Heurteaux C., and Lazdunski M. (2000) K(ATP) channel openers, adenosine agonists and epileptic preconditioning are stress signals inducing hippocampal neuroprotection. Neuroscience 100, 465-474.
3. Blondeau N., Widmann C., Lazdunski M., and Heurteaux C. (2001) Activation of the nuclear factor-kappaB is a key event in brain tolerance. J. Neurosci. 21, 4668-4677.
4. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
5. Chiarugi A. (2002) Characterization of the molecular events following impairment of NF-kappaB-driven transcription in neurons. Brain Res. Mol. Brain Res. 109, 179-188.
6. Clemens J.A. (2000) Cerebral ischemia: gene activation, neuronal injury, and the protective role of antioxidants. Free Radic. Biol. Med. 28, 1526-1531.
7. Di Capua N., Sperling O., and Zoref-Shard E. (2003) Protein kinase C-ε is involved in the adenosine-activated signal transduction pathway conferring protection against ischemia-reperfusion injury in primary rat neuronal cultures. J. Neurochem. 84, 409-412.
8. Fridmacher V., Kaltschmidt B., Goudeau B., Ndiaye D., Rossi F. M., Pfeiffer J., et al. (2003) Forebrain-specific neuronal inhibition of nuclear factor-kappaB activity leads to loss of neuroprotection. J. Neurosci. 23, 9403-9408.
9. Heck S., Lezoualc'h F., Engert S., and Behl C. (1999) Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor kappaB. J. Biol. Chem. 274, 828-835.
10. Kaltschmidt B., Uherek M., Wellmann H., Volk B., and Kaltschmidt C. (1999) Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis. Proc. Natl. Acad. Sci. U. S. A. 96, 409-414.
11. Karin M. and Lin A. (2002) NF-kappaB at the crossroads of life and death. Nat. Immunol. 3, 221-227.
12. Karin M., Takahashi T., Kapahi P., Delhase M., Chen Y., Makris C., et al. (2001) Oxidative stress and gene expression: the AP-1 and NF-kappaB connections. Biofactors 15, 87-89.
13. Kirino T., Tsujita Y., and Tamura A. (1991) Induced tolerance to ischemia in gerbil hippocampal neurons. J. Cereb. Blood Flow Metab. 11, 299-307.
14. Kitagawa K., Matsumoto M., Tagaya M., Hata R., Ueda H., Niinobe M., et al. (1990) 'Ischemic tolerance' phenomenon found in the brain. Brain Res. 528, 21-24.
15. Lezoualc'h F. and Behl C. (1998) Transcription factor NF-kappaB: friend or foe of neurons? Mol. Psychiatry 3, 15-20.
16. Lin B., Williams-Skipp C., Tao Y., Schleicher M. S., Cano L. L, Duke R. C., et al. (1999) NF-kappaB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type. Cell Death Differ. 6, 570-582.
17. Lin Y. Z., Yao S. Y., Veach R. A., Torgerson T. R., and Hawiger J. (1995) Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem. 270, 14255-14258.
18. Mercurio F. and Manning A. M. (1999) NF-kappaB as a primary regulator of the stress response. Oncogene 18, 6163-6171.
19. Nurmi A., Vartiainen N., Pihlaja R., Goldsteins G., Yrjanheikki J., and Koistinaho J. (2004) Pyrrolidine dithiocarbamate inhibits translocation of nuclear factor kappa-B in neurons and protects against brain ischaemia with a wide therapeutic time window. J. Neurochem. 91, 755-765.
20. Perkins N. D. (2000) The Rel/NF-kappa B family: friend and foe. Trends Biochem. Sci. 25, 434-440.
21. Piccioli P., Porcile C., Stanzione S., Bisaglia M., Bajetto A., Bonavia R., et al. (2001) Inhibition of nuclear factor-kappaB activation induces apoptosis in cerebellar granule cells. J. Neurosci. Res. 66, 1064-1073.
22. Ravati A., Ahlemeyer B., Becker A., Klumpp S., and Krieglstein J. (2001) Preconditioning-induced neuroprotection is mediated by reactive oxygen species and activation of the transcription factor nuclear factor-kappaB. J. Neurochem. 78, 909-919.
23. Reshef A., Sperling O., and Shani E. (2000) The adenosine-induced mechanism for the acquisition of ischemic tolerance in primary rat neuronal cultures. Pharmacol. Ther. 87, 151-159.
24. Schreck R., Meier B., Mannel D. N., Droge W., and Baeuerle P. A. (1992) Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J. Exp. Med. 175, 1181-1194.
25. Schreck R., Rieber P., and Baeuerle P. A. (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappaB transcription factor and HIV-1. EMBO J. 10, 2247-2258.
26. Shimazaki K., Ishida A., and Kawai N. (1994) Increase in bcl-2 oncoprotein and the tolerance to ischemia-induced neuronal death in the gerbil hippocampus. Neurosci. Res. 20, 95-99.
27. Shou Y., Li N., Li L., Borowitz J. L., and Isom G. E. (2002) NF-kappaB-mediated up-regulation of Bcl-X(S) and Bax contributes to cytochrome c release in cyanide-induced apoptosis. J. Neurochem. 81, 842-852.
28. Sperling O., Bromberg Y., Oelsner H., and Zoref-Shani E. (2003) Reactive oxygen species play an important role in iodoacetate-induced neurotoxicity in primary rat neuronal cultures and in differentiated PC12 cells. Neurosci. Lett. 351, 137-140.
29. Storz P., Doppler H., and Toker A. (2004) Protein kinase Cdelta selectively regulates protein kinase D-dependent activation of NF-kappaB in oxidative stress signaling. Mol. Cell. Biol. 24, 2614-2626.
30. Toyoda T., Kassell N. F., and Lee K. S. (1997) Induction of ischemic tolerance and antioxidant activity by brief focal ischemia. Neuroreport 8, 847-851.
31. Wang T., Zhang X., and Li J. J. (2002) The role of NF-kappaB in the regulation of cell stress responses. Int. Immunopharmacol. 2, 1509-1520.
32. Ziegler-Heitbrock H. W., Sternsdorf T., Liese J., Belohradsky B., Weber C., Wedel A., et al. (1993) Pyrrolidine dithiocarbamate inhibits NF-kappaB mobilization and TNF production in human monocytes. J. Immunol. 151, 6986-6993.